A Clinical Study to Evaluate the Use of a Cryopreserved Formulation of OTL-103 in Subjects With Wiskott-Aldrich Syndrome
Clinical trial NCT03837483 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03837483
- Sponsor
- Fondazione Telethon
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-21
- Primary completion
- 2024-03-18
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.